Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 11, 2006
J Am Soc Nephrol 17: 2974-2984, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006040377

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006040377v1
17/11/2974    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbate, M.
Right arrow Articles by Remuzzi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbate, M.
Right arrow Articles by Remuzzi, G.
Related Collections
Right arrowRelated Article

Frontiers in Nephrology

How Does Proteinuria Cause Progressive Renal Damage?

Mauro Abbate*, Carla Zoja* and Giuseppe Remuzzi*,{dagger}

* Mario Negri Institute for Pharmacological Research and {dagger} Unit of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy

Address correspondence to: Dr. Giuseppe Remuzzi, "Mario Negri" Institute for Pharmacological Research, Via Gavazzeni, 11, 24125 Bergamo, Italy. Phone: +39-035-319-888; Fax: +39-035-319-331; E-mail: gremuzzi{at}marionegri.it

The possibility that proteinuria may accelerate kidney disease progression to end-stage renal failure has received support from the results of increasing numbers of experimental and clinical studies. Evidence indicating that this process occurs through multiple pathways, including induction of tubular chemokine expression and complement activation that lead to inflammatory cell infiltration in the interstitium and sustained fibrogenesis, is reviewed. Macrophages are prominent in the interstitial inflammatory infiltrate. This cell type mediates progression of renal injury to the extent that macrophage numbers in renal biopsy predict renal survival in patients with chronic renal disease. Chemoattractants and adhesive molecules for inflammatory cells are upregulated by excess ultrafiltered protein load of proximal tubular cells via activation of NF-{kappa}B–dependent and NF-{kappa}B–independent pathways. This mechanism is a potential target for therapeutic approaches, as shown by beneficial effects of manipulations with inhibitory molecules of NF-{kappa}B activation or of chemokine receptors in experimental studies. Targeting complement synthesis or activation in proximal tubule might offer novel therapeutic opportunities. Finally, proximal tubular cell receptors for uptake of plasma proteins that are under investigation may provide activation signals on excess tubular protein handling.


Related Article

Relationship between Urinary Albumin Excretion and Left Ventricular Mass with Mortality in Patients with Type 2 Diabetes
Niloofar Nobakhthaghighi, Mohammed Kamgar, Mir R. Bekheirnia, Kim McFann, Raymond Estacio, and Robert W. Schrier
Clin. J. Am. Soc. Nephrol. 2006 1: 1187-1190. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. Zheng, E. C. Carlson, L. Yang, P. M. Kralik, Y. Huang, and P. N. Epstein
Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2077 - 2085.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. T. Lindenmeyer, M. P. Rastaldi, M. Ikehata, M. A. Neusser, M. Kretzler, C. D. Cohen, and D. Schlondorff
Proteinuria and Hyperglycemia Induce Endoplasmic Reticulum Stress
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2225 - 2236.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Soares, J. S. S. Diniz, E. M. Lima, G. R. Oliveira, M. R. Canhestro, E. A. Colosimo, A. C. Simoes e Silva, and E. A. Oliveira
Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme
Nephrol. Dial. Transplant., October 13, 2008; (2008) gfn547v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Koop, M. Eikmans, M. Wehland, H. Baelde, D. Ijpelaar, R. Kreutz, H. Kawachi, D. Kerjaschki, E. de Heer, and J. A. Bruijn
Selective Loss of Podoplanin Protein Expression Accompanies Proteinuria and Precedes Alterations in Podocyte Morphology in a Spontaneous Proteinuric Rat Model
Am. J. Pathol., August 1, 2008; 173(2): 315 - 326.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. M. van Timmeren, M.-L. Gross, W. Hanke, P. A. Klok, H. van Goor, C. A. Stegeman, and S. J. L. Bakker
Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury
Nephrol. Dial. Transplant., July 24, 2008; (2008) gfn417v1.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. J. Birmingham, B. H. Rovin, G. Shidham, M. Bissell, H. N. Nagaraja, and L. A. Hebert
Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus Nephritis: Diagnostic and Therapeutic Implications
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1028 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate, C. Zoja, D. Corna, D. Rottoli, C. Zanchi, N. Azzollini, S. Tomasoni, S. Berlingeri, M. Noris, M. Morigi, et al.
Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1158 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. G. Machado, E. P. B. Poppi, C. Fanelli, D. M. A. C. Malheiros, R. Zatz, and C. K. Fujihara
AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1345 - F1353.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Bolignano, G. Coppolino, S. Campo, C. Aloisi, G. Nicocia, N. Frisina, and M. Buemi
Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 414 - 416.
[Full Text] [PDF]


Home page
haematolHome page
R. Sitia, G. Palladini, and G. Merlini
Bortezomib in the treatment of AL amyloidosis: targeted therapy?
Haematologica, October 1, 2007; 92(10): 1302 - 1307.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP